Comparison of regimens of amphotericin B deoxycholate in kala-azar

Indian Journal of Medical Research

Volumn 103, Issue MAY, 1996, Pages 259-263

  Thakur, C P ^a,b   Sinha, G P ^a   Pandey, A K ^a  

^a PATNA MEDICAL COLLEGE AND HOSPITAL   (India)

^b NONE   (India)

Author keywords

Amphotericin B; Amphotericin B toxicity; Antimony resistance; Kala azar

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CREATININE; POTASSIUM;

ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RIGOR; SHIVERING;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DEOXYCHOLIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0029989028     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Thakur CP. Diminishing effectiveness of currently used drugs in treatment of kala-azar and on the effect of amphotericin B in antimony and pentamidine-resistant kala-azar. In: Bhaduri AN, Basu MK, Sen AK, Sushil Kumar, editors. Current trends in leishmania research. New Delhi : Publications and Information Directorate, Council for Scientific and Industrial Research, 1993: 255-62.
2. Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK. Amphotericin B in resistant kala-azar in Bihar. Natl Med J India 1993; 6: 57-60.
3. Thakur CP, Sinha GP, Sharma V, Pandey AK, Sinha PK, Barat D. Efficacy of amphotericin B in multi drug resistant kala-azar in children in the first decade of life. Indian J Paediatr 1993; 60: 29-36.
4. Berman JD, Wyler DJ. An in vitro model for investigation of chemotheraputic agents in leishmania. J Infect Dis 1980: 142 : 83-6.
5. Gallis HA, Drew R, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12: 308-29.
6. Mishra M, Biswas UK, Jha DN Khan AB. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet 1992; 340: 1256-7.
7. Locksley RM. Leishmaniasis. In: Isselbacher KJ, Braunwakl E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's principles of internal medicine, 13th ed: New York : McGraw Hill Inc. 1994: 896-9.
8. The leishmaniasis. Report of a WHO Expert Committee. WHO Tech Rep Ser 104, Geneva : World Health Organisation. 1984: 138-9.
9. Determination of blood urea. Urease nesslerization method. In: Varley H, editor. Practical clinical biochemistry. 4th ed. London: William Heinemann Medical Book Ltd., 1967: 158- 67.
10. Determination of creatinine and creatine in blood. In: Varley H. editor. Practical clinical biochemistry, 4th ed. London: William Heinemann Medical Books Ltd. 1967: 199-201.
11. Colorimetric method for aspartate and alanine transaminases using 2-4dinitrophenylhydrzrine. In: Varley H, editor. Practical clinical biochemistry, 4th ed. London : William Heinemann Medical Books Ltd. 1967: 293-5.
12. Thakur CP, Sinha GP, Barat D, Singh RK. Two hour versus six hour administration of amphotericin B in the treatment of kala-azar. Int J Antimicrob Agents 1995; 5: 115-7
13. Thakur CP, Sinha GP, Pandey AK, Barat D, Singh RK. Daily versus alternate day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison. Bull WHO 1994; 72 : 931-36.
14. Thakur CP, Sinha GP, Barat D, Singh RK. Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? Ann Trop Med Parasitol 1994; 88: 365-70.
15. Grogl M, Oduola AMJ. Cordero LDC, Kyle DE. Leishnania spp: Development of pentostam-resistant clones in vitro by discontinuous drug exposure. Exp Parasitol 1989; 69: 78-90.
16. Grogl M, Thomason TN, Franke ED. Drug resistance in leishmaniasis: its implications in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 1992; 47: 117-26.
17. Dick JO, Merz WJ, Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980; 18: 158-63.
18. Hebeka EK. Salotorovsky M. Development of resistance to polyene antibiotics in Candida albicans. J Bacteriol 1965; 89 : 1533-9.
19. Warnock D. Amphotericin B. An Introduction. J Antimicrob Chemather 1991; 28: Suppl B: 27-38.
20. Butler WT, Bennett J, Alling DW, Wertlake PT, Utz J, Hill G. Nephrotoxicity of amphotericin B Early and late effects in 81 patients. Ann Intern Med 1969; 61: 175-87.
21. Thakur CP. Correction of serum electrolyte imbalance prevents cardiac arrythmia during amphotericin B administration. Natl Med J India 1995; 8: 13-4.